Clinical Trial Update: Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates [Phase 2]

View source ↗

Summary

Phase 2, single-arm trial evaluating rectal cancer brachytherapy for low-lying residual rectal adenocarcinoma after total neoadjuvant therapy to improve organ p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Snippet

Sponsor: University of Colorado, Denver | Conditions: Rectal Adenocarcinoma, Rectal Cancer | Phase 2 | Status: RECRUITING